Indian Children With Cancer Face Long Journeys to Reach Specialist Treatment Centres
A study highlights geographical barriers to accessing paediatric cancer care in India.
A study published in the Journal of Cancer Policy found that many children with cancer in India must travel long distances to reach specialised paediatric cancer centres. The report highlights how travel time can delay access to diagnosis, treatment and follow-up care.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Children diagnosed with cancer often require specialised care involving paediatric oncologists, diagnostic facilities, chemotherapy services, surgery and supportive treatment. These services are not equally available in every district, which can force families to travel to larger cities or regional hospitals.
The study highlighted the geographical barriers faced by Indian families seeking paediatric cancer treatment. Some children need to travel for more than two hours to reach a specialist centre. Such journeys can create financial pressure, disrupt education and increase the burden on caregivers.
Long travel distances may also make it harder for families to attend repeated appointments and complete treatment schedules. The findings underline the importance of strengthening regional cancer services, referral networks, accommodation support and transport assistance.
Improving access to specialist treatment closer to where children live could help reduce the practical and financial difficulties associated with childhood cancer care.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
